Compare the exact presentation, strength, supply period and conditions—not the lowest number on a landing page. The following is a November 17 research snapshot of selected manufacturer programmes. It excludes clinic care fees and does not establish clinical interchangeability or a universally available price.
| Product and presentation | Published self-pay reference | Conditions that matter to the quote |
|---|---|---|
| Zepbound single-dose vials or single-patient-use KwikPen | $299 at 2.5 mg; $399 at 5 mg; $449 at 7.5–15 mg under the Journey offer | A month is 28 days. Higher-strength offer pricing requires timely refilling within 45 days; regular prices differ if the condition is missed. Injection supplies require purchase. (lilly.com) |
| Wegovy standard injection | Qualifying introductory fills: $199 at 0.25 mg and 0.5 mg; published continuing price: $349 | Two introductory fills through December 31, 2026. One month is a box of four pens; reconfirm future programme terms. (novocare.com) |
| Wegovy HD injection, 7.2 mg | $399 | Separate presentation and prescribed strength; do not blend into standard-injection pricing. (novocare.com) |
| Wegovy tablets | $149 at 1.5 mg; $199 at 4 mg; $299 at 9 mg and 25 mg | One bottle contains 30 tablets. Eligibility and programme restrictions apply. (novocare.com) |
| Foundayo tablets | $149 at 0.8 mg and 2.5 mg; $199 at 5.5 mg; $299 at 9 mg, 14.5 mg and 17.2 mg | Thirty-day supply. Discounts at 2.5 mg and 5.5 mg run through December 31, 2026; the top two strengths have a 45-day refill condition for Journey pricing. Additional taxes or fees may apply. (lilly.com) |
Zepbound 2.5 mg is a starting dose, not an approved maintenance dose. Do not use its advertised price as the default continuing-treatment assumption. (lilly.com)
For your GLP-1 clinic cost model: use prescribed dose-mix assumptions supplied by clinical leadership. Count the actual packs needed over the chosen period; do not silently equate 28-day packs, 30-tablet bottles and calendar months.
Explore the table row by row
A working view of the research
Zepbound single-dose vials or single-patient-use KwikPen
- Published self-pay reference
- $299 at 2.5 mg; $399 at 5 mg; $449 at 7.5–15 mg under the Journey offer
- Conditions that matter to the quote
- A month is 28 days. Higher-strength offer pricing requires timely refilling within 45 days; regular prices differ if the condition is missed. Injection supplies require purchase. (lilly.com)
Sources cited on this page
- lilly.com · Source 1 ↗https://www.lilly.com/lillydirect/zepbound?utm_source=openai
- novocare.com · Source 2 ↗https://www.novocare.com/patient/medicines/wegovy/savings-offer.html
- lilly.com · Source 3 ↗https://www.lilly.com/lillydirect/foundayo